2024 Seattle Lung Cancer Conference

2024 Seattle Lung Cancer Conference is organized by Binaytara Foundation (BTF), Fred Hutchinson Cancer Center and will be held on Nov 02, 2024 at Hilton Motif Seattle, Seattle, Washington, United States of America.

Description:
This CME-accredited activity, the 2024 Seattle Lung Cancer Conference, brings together leaders in the field of thoracic oncology to provide an extensive overview of both current and emerging strategies for managing lung cancer (NSCLC and SCLC). The primary aim of this conference is to enhance the knowledge and competence of participants, enabling them to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for lung cancer patients. The program includes detailed discussions and analyses of the latest scientific discoveries and advancements in molecular testing and targeted therapies for thoracic oncology. The expert faculty will focus on the clinical application of diagnostics, biomarkers, and various therapeutic agents, discussing how these tests and treatments can be effectively used to improve patient care.

Learning Objectives:
At the conclusion of the activity, participants will be able to:
• Review the various actionable molecular abnormalities in lung cancer and learn about the appropriate testing and treatment strategies for these alterations.
• Summarize the efficacy and potential toxicities of immune checkpoint inhibitors, targeted therapies, and other chemotherapy agents in the management of lung cancer.
• Identify the role of perioperative systemic therapy options in curative-intent treatment of non-small cell lung cancer (NSCLC), including chemotherapy, immune checkpoint inhibitors, and targeted therapies.
• Apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with lung cancer.